|This Slide: #28 of 100|
Slide #28. Chindex International, Inc. — TPG and Fosun Pharma
Chindex International, Inc. (CHDX)
TPG and Fosun Pharma
Chindex International, Inc. (NASDAQ: CHDX) ("Chindex" or the "Company"), an American healthcare company providing services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, announced that it has entered into an amended and restated merger agreement (the "Amended Agreement") relating to the merger (the "Merger") among the Company, the existing buyer consortium (the "Buyer Consortium") comprised of an affiliate of TPG (together with its affiliates, "TPG"), Fosun Industrial Co., Limited ("Fosun"), which is an affiliate of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"), and Ms. Roberta Lipson, the CEO of the Company, and a merger subsidiary of the Buyer Consortium providing for an increase in the merger consideration from $19.50 per share in cash to $24.00 per share in cash.
Chindex International is a health care company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. As of Dec 31 2013 Co.'s operations consisted of: its Beijing hospital with 120 licensed beds; the 101 licensed bed United Family Rehabilitation Hospital located in Beijing; five separate freestanding clinics in Beijing; a freestanding outpatient cancer treatment center in Beijing; its Shanghai hospital, which provides 50 licensed beds; three medical clinics and one dental clinic in Shanghai; its Tianjin hospital, which provides 26 licensed beds; and its Guangzhou clinic.
Open the CHDX Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite